Hao Fujie, Zhu Qin, Wang Sue, Liu Ya, Jiang Lin, Pan Ruili
School of Nursing, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100144, China.
Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100010, China.
Zhongguo Fei Ai Za Zhi. 2022 Jul 20;25(7):501-505. doi: 10.3779/j.issn.1009-3419.2022.102.30.
Clinical trials of anti-tumor drugs is not only the important way to develop new drugs, but also the most advanced treatment methods for malignant tumors, bringing survival benefits to patients. There are a large number of new anti-tumor drug clinical trials for lung cancer patients, covering a wide variety of anti-tumor drugs, and with rapid progress and high efficiency of clinical transformation. These trials could not be carried out successfully without the joint efforts of the research team, in which the research nurses also played a role that should not be underestimated. Combined with the work content of clinical research nurses, this paper introduced the post management, role function, core competence and career development prospect of clinical research nurses in the process of carrying out clinical trial of lung cancer drugs in detail. In order to provide reference for more medical institutions to carry out related work, and promote the further development of clinical research nurses to standardization and specialization. .
抗肿瘤药物临床试验不仅是新药研发的重要途径,也是恶性肿瘤最先进的治疗方法,能为患者带来生存益处。针对肺癌患者有大量新的抗肿瘤药物临床试验,涵盖多种抗肿瘤药物,且临床转化进展迅速、效率高。没有研究团队的共同努力,这些试验无法成功开展,其中研究护士也发挥了不可低估的作用。结合临床研究护士的工作内容,本文详细介绍了临床研究护士在开展肺癌药物临床试验过程中的岗位管理、角色功能、核心能力及职业发展前景。旨在为更多医疗机构开展相关工作提供参考,推动临床研究护士向规范化、专业化方向进一步发展。